Spain's AATRM HTA agency to appraise PET/CT use
This article was originally published in Clinica
The health technology assessment (HTA) agency for the Catalan regional government, AATRM, has been asked to carry out a survey of positron emission tomography (PET) and computed tomography (CT) use across the region. The survey is part of a diagnostic imaging programme (PDI) set up by the regional health department, which aims, among other things, to promote the "appropriate and rational use" of diagnostic imaging techniques. The AATRM will appraise the use of PET and CT at all centres offering these techniques. The study will also incorporate the opinion of clinicians in this area.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.